ized controlled trial.
Adapted from Guyatt G et al.23

In accordance with the American College of Chest
Physicians (ACCP) guidelines for the antithrombotic treatment of venous thromboembolic disease,24 we have adopted the language of “recommending” the use of strong
Grade 1 guidelines and “suggesting” the use of weaker
Grade 2 guidelines.
Although trial methodology is related to the quality of
the evidence,